Detailed information for compound 349831

Basic information

Technical information
  • TDR Targets ID: 349831
  • Name: 2-[4-(2,4-dioxo-1,3-dipropyl-5H-pyrrolo[3,2-d ]pyrimidin-6-yl)phenoxy]-N-(4-phenylmethoxyph enyl)acetamide
  • MW: 566.647 | Formula: C33H34N4O5
  • H donors: 2 H acceptors: 3 LogP: 5.72 Rotable bonds: 13
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCCn1c2cc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)OCc1ccccc1
  • InChi: 1S/C33H34N4O5/c1-3-18-36-29-20-28(35-31(29)32(39)37(19-4-2)33(36)40)24-10-14-26(15-11-24)42-22-30(38)34-25-12-16-27(17-13-25)41-21-23-8-6-5-7-9-23/h5-17,20,35H,3-4,18-19,21-22H2,1-2H3,(H,34,38)
  • InChiKey: BEDJXTZHYOLEPQ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-(4-benzyloxyphenyl)-2-[4-(2,4-dioxo-1,3-dipropyl-5H-pyrrolo[3,2-d]pyrimidin-6-yl)phenoxy]acetamide
  • 2-[4-(2,4-dioxo-1,3-dipropyl-5H-pyrrolo[3,2-d]pyrimidin-6-yl)phenoxy]-N-(4-phenylmethoxyphenyl)ethanamide
  • N-(4-benzoxyphenyl)-2-[4-(2,4-diketo-1,3-dipropyl-5H-pyrrolo[3,2-d]pyrimidin-6-yl)phenoxy]acetamide
  • 2-[4-(2,4-dioxo-1,3-dipropyl-5H-pyrrolo[4,5-d]pyrimidin-6-yl)phenoxy]-N-[4-(phenylmethoxy)phenyl]acetamide
  • N-[4-(benzyloxy)phenyl]-2-[4-(2,4-diketo-1,3-dipropyl-5H-pyrrolo[4,5-d]pyrimidin-6-yl)phenoxy]acetamide
  • 2-[4-(2,4-dioxo-1,3-dipropyl-5H-pyrrolo[4,5-d]pyrimidin-6-yl)phenoxy]-N-[4-(phenylmethoxy)phenyl]ethanamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens adenosine A2a receptor Starlite/ChEMBL References
Homo sapiens adenosine A2b receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi follicle stimulating hormone receptor adenosine A2a receptor 412 aa 336 aa 22.3 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0038 0.5 0.5
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0038 0.5 0.5
Onchocerca volvulus 0.0038 0.5 0.5
Loa Loa (eye worm) carboxylesterase 0.0038 0.5 0.5
Echinococcus granulosus BC026374 protein S09 family 0.0038 0.5 0.5
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0038 0.5 0.5
Mycobacterium ulcerans carboxylesterase, LipT 0.0038 0.5 0.5
Echinococcus multilocularis family S9 non peptidase ue (S09 family) 0.0038 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0038 0.5 0.5
Schistosoma mansoni acetylcholinesterase 0.0038 0.5 0.5
Echinococcus granulosus carboxylesterase 5A 0.0038 0.5 0.5
Onchocerca volvulus 0.0038 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0038 0.5 0.5
Trichomonas vaginalis carboxylesterase domain containing protein, putative 0.0038 0.5 0.5
Echinococcus multilocularis acetylcholinesterase 0.0038 0.5 0.5
Echinococcus granulosus neuroligin 0.0038 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0038 0.5 0.5
Mycobacterium tuberculosis Carboxylesterase LipT 0.0038 0.5 0.5
Loa Loa (eye worm) carboxylesterase 0.0038 0.5 0.5
Onchocerca volvulus 0.0038 0.5 0.5
Onchocerca volvulus 0.0038 0.5 0.5
Echinococcus multilocularis carboxylesterase 5A 0.0038 0.5 0.5
Echinococcus granulosus family S9 non peptidase ue S09 family 0.0038 0.5 0.5
Schistosoma mansoni neuroligin 3 (S09 family) 0.0038 0.5 0.5
Brugia malayi Carboxylesterase family protein 0.0038 0.5 0.5
Brugia malayi Carboxylesterase family protein 0.0038 0.5 0.5
Echinococcus granulosus acetylcholinesterase 0.0038 0.5 0.5
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0038 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0038 0.5 0.5
Echinococcus multilocularis BC026374 protein (S09 family) 0.0038 0.5 0.5
Schistosoma mansoni BC026374 protein (S09 family) 0.0038 0.5 0.5
Echinococcus multilocularis para nitrobenzyl esterase 0.0038 0.5 0.5
Brugia malayi hypothetical protein 0.0038 0.5 0.5
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0038 0.5 0.5
Trichomonas vaginalis spcc417.12 protein, putative 0.0038 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0038 0.5 0.5
Onchocerca volvulus 0.0038 0.5 0.5
Brugia malayi Carboxylesterase family protein 0.0038 0.5 0.5
Echinococcus multilocularis acetylcholinesterase 0.0038 0.5 0.5
Loa Loa (eye worm) acetylcholinesterase 1 0.0038 0.5 0.5
Brugia malayi Carboxylesterase family protein 0.0038 0.5 0.5
Echinococcus granulosus acetylcholinesterase 0.0038 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0038 0.5 0.5
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0038 0.5 0.5
Loa Loa (eye worm) carboxylesterase 0.0038 0.5 0.5
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0038 0.5 0.5
Brugia malayi Carboxylesterase family protein 0.0038 0.5 0.5
Schistosoma mansoni gliotactin 0.0038 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0038 0.5 0.5
Echinococcus granulosus para nitrobenzyl esterase 0.0038 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0038 0.5 0.5
Echinococcus multilocularis neuroligin 0.0038 0.5 0.5

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) = 49 % Displacement of [3H]DPCPX from recombinant human adenosine A2B receptor expressed in HeLa cells at 0.01 uM ChEMBL. 16392813
Inhibition (binding) = 49 % Displacement of [3H]DPCPX from recombinant human adenosine A2B receptor expressed in HeLa cells at 0.01 uM ChEMBL. 16392813
Inhibition (binding) = 60 % Displacement of [3H]ZM241385 from recombinant human adenosine A2A receptor expressed in HEK293 cells at 0.1 uM ChEMBL. 16392813
Inhibition (binding) = 60 % Displacement of [3H]ZM241385 from recombinant human adenosine A2A receptor expressed in HEK293 cells at 0.1 uM ChEMBL. 16392813
Inhibition (binding) = 76 % Displacement of [3H]DPCPX from recombinant human adenosine A2B receptor expressed in HEK293 cells at 0.1 uM ChEMBL. 16392813
Inhibition (binding) = 76 % Displacement of [3H]DPCPX from recombinant human adenosine A2B receptor expressed in HEK293 cells at 0.1 uM ChEMBL. 16392813
Ki (binding) = 7.73 Binding affinity to recombinant human adenosine A2A receptor ChEMBL. 16392813
Ki (binding) = 8.05 Binding affinity to recombinant human adenosine A2B receptor ChEMBL. 16392813
Log Ki (binding) = 7.73 Binding affinity to recombinant human adenosine A2A receptor ChEMBL. 16392813
Log Ki (binding) = 8.05 Binding affinity to recombinant human adenosine A2B receptor ChEMBL. 16392813
Ratio Ki (binding) = 2.1 Selectivity for human adenosine A2B over human adenosine A2A receptor ChEMBL. 16392813

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.